Cohort has announced that it expects FY21 trading to be in line with consensus expectations, with a better-than-expected cash performance and a record order intake spread across most of the group. However, the Portuguese subsidiary EID has experienced significant order deferrals and leads us to reduce our FY22 EPS estimates by 7%. It leaves the shares trading on an FY22e P/E of 19.9x, a premium to UK defence peers, before growth resumes in FY23 aided by an assumed recovery at EID.
26 May 2021
Cohort - Solid progress through the pandemic
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cohort - Solid progress through the pandemic
Cohort plc (CHRT:LON) | 669 0 0.0% | Mkt Cap: 277.7m
- Published:
26 May 2021 -
Author:
Andy Chambers -
Pages:
4
Cohort has announced that it expects FY21 trading to be in line with consensus expectations, with a better-than-expected cash performance and a record order intake spread across most of the group. However, the Portuguese subsidiary EID has experienced significant order deferrals and leads us to reduce our FY22 EPS estimates by 7%. It leaves the shares trading on an FY22e P/E of 19.9x, a premium to UK defence peers, before growth resumes in FY23 aided by an assumed recovery at EID.